Global Flow Cytometry Market is Expected to Grow at a CAGR of 9% in the Forecast Period 2020-2025.

The global flow cytometry market is expected to be driven by the emergence of advanced techniques, like high-throughput multifunctional analysis, fast detection, higher resolution, and better cell sorting, ensuring increased efficiency in the classification and identification of newer drugs. In 2019, cell-based devices dominated the overall market and is anticipated to retain its lead over the forecast period. The increasing demand for early diagnosis, as well as the increased awareness of the advantages of cell-based research are the factors that are driving the demand in the market. In addition, the technology is commonly used in various fields of research. These measures are used for the physiological importance of the findings in drug discovery. The innovation of instruments, labels, affinity reagents, software, as well as algorithms, are the major technological advancements in cell-based research. For example, the recently introduced automated microcapillary cytometry is a time-saving and cost-effective technique for cell analysis.

North America led the global flow cytometry market in 2019 owing to supporting government policies for the advancement of advanced molecular diagnostics technologies. It is expected to maintain its dominance over the forecast years as skilled professionals are available, and awareness among consumers is higher. Because of the high incidence of cancer as well as other chronic diseases, the United States is the largest market in North America. In addition, the presence of numerous clinical and pharmaceutical laboratories in the United States is likely to contribute to the growth of the flow cytometry market.

In June 2019, Becton, Dickinson and Company (NYSE: BDX), one of the key players, announced the launch of FlowJoTM software version 10.6 for flow cytometry data analysis. The software adds new analytic capabilities and improves BD FACSDivaTM functionality, making evaluating multiple flow cytometry running and comparing data in one view simpler for consumers.

Market Analysis by Devices, Product, Application, End Use, and Regions:

• The devices in the market can be divided into cell-based and bead-based.
• Based on product, the industry can be segmented into instruments, reagents and consumables, software, accessories, services, and others.
• Flow cytometry finds application in oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, and haematology, among others.
• The end-uses of flow cytometry include academic and research institutes, hospitals and clinical testing laboratories, and pharmaceutical and biotechnology companies.
• The regional markets include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The rising use in stem cell, as well as clinical research, is driving the market growth of flow cytometry.
• The rising advancements in the technologies used in flow cytometry are propelling the growth further.
• The increasing use of flow cytometry in the R&D industry in the health care sector is aiding the market growth.
• The increasing cases of HIV AIDS and cancer can aid the market development as flow cytometry is the ideal tool for detection.
• The rising development and urbanisation in several countries are also providing an impetus to the market growth.

Key Offerings of the Report:

• The EMR report gives an analysis of the global flow cytometry market for the periods (2015-2019) and (2020-2025).
• The report also offers the historical (2015-2019) and forecasted (2020-2025) markets for the devices, products, applications, end-uses, and major regional markets of flow cytometry.
• The EMR report also provides an insight into the price and demand indicators of the global flow cytometry market.

The major key players in the global flow cytometry market include companies like Sysmex Corporation, Apogee Flow Systems Ltd., Beckman Coulter [Danaher], Becton, Dickinson and Company, bioMérieux SA, Life Technologies Corporation [Thermo Fisher Scientific], Bio-Rad Laboratories, Inc., Cytonome/ST LLC, Enzo Life Science, Inc. [Enzo Biochem, Inc.], and Merck KGaA, among others. The comprehensive report covers their market share, capacity, and latest developments like mergers and acquisitions, and capacity expansions.

About Us:

EMR is a leading business intelligence company, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At EMR, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790